Results 171 to 180 of about 145,091 (327)

Erythrokeratodermia‐Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions

Pediatric Dermatology, EarlyView.
ABSTRACT Erythrokeratodermia cardiomyopathy (EKC) syndrome is a rare autosomal dominant disorder characterized by generalized erythrokeratoderma and progressive dilated cardiomyopathy, caused by pathogenic variants in the SR6 domain of desmoplakin (DSP).
Sepideh Hamzehlou, Ryland D. Mortlock, Caroline Echeandia‐Francis, Jing Zhou, Chao Xing, Nnenna G. Agim, Keith A. Choate, Donald A. Glass II   +7 more
wiley   +1 more source

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

Experimental Physiology, EarlyView.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber, Kiana M. Schulze, Andrew G. Horn, Tyler E. McCoach, Zachary J. White, K. Sue Hageman, Stephanie E. Hall, Peter Sandner, Brad J. Behnke, Timothy I. Musch, David C. Poole   +10 more
wiley   +1 more source

469 Comparison of reverse remodeling in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy after cardiac resynchronization therapy [PDF]

, 2005
Antonella Moreo, Benedetta De Chiara, G. Cattaft, Marina Parolini, Fabrizio Oliva, G. Santambrogio, M. Lunali, Francesco Mauri   +7 more
openalex   +1 more source

Nonischemic Dilated Cardiomyopathy

Reviews in Cardiovascular Medicine, 2014
Norman E, Lepor, Gerald, Pohost, Donna, Gallik   +2 more
openaire   +2 more sources

EuroSCORE II: Current limitations and physiological gaps in risk stratification

Experimental Physiology, EarlyView.
Abstract Risk stratification remains critical in cardiac surgery, enabling clinicians to predict adverse outcomes and guide perioperative management. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, introduced in 2011, incorporates 18 key variables to provide an evidence‐based approach to risk assessment.
Jing Yong Ng, Eu Fon Tan, Marsioleda Kemberi, Eduardo Urgesi, Matti Jubouri, Damian M. Bailey, Mohamad Bashir, Wael I. Awad   +7 more
wiley   +1 more source

Dilated Cardiomyopathy in Behcet′s Disease in a Young Male Patient

, 2017
Hamid Khederlou, Samin Taheri, Alireza Sadeghi, Amirhossein Moghtader Mojdehi   +3 more
openalex   +2 more sources

Distinct profiles of mitochondrial bioenergetics and redox balance in left atrial and ventricular myocardium in the healthy rat heart

Experimental Physiology, EarlyView.
Abstract The left ventricle (LV) is the primary pumping chamber of the heart, generating high systolic pressure to sustain systemic circulation. LV contractile dysfunction is a hallmark of various cardiovascular diseases and is associated with mitochondrial dysfunction, characterised by decreased oxidative phosphorylation (OXPHOS) capacity and ...
Tingting Fang, Alex Chan, Janice Chew‐Harris, Toan Pham   +3 more
wiley   +1 more source

Metabolic Modulation in Dilated Cardiomyopathy: From Pathophysiology to Therapy. [PDF]

Rev Cardiovasc Med
Nie X, Lu Z.
europepmc   +1 more source

The causative role of amyloidosis in the cardiac complications of Alzheimer's disease: a comprehensive systematic review

The Journal of Physiology, EarlyView.
Abstract figure legend Schematic illustration of the bidirectional causative link between cerebral amyloid‐beta (Aβ) angiopathy and cardiovascular disease in Alzheimer's disease (AD). Common cardiovascular risk factors like microvascular thrombosis, diabetes, atrial fibrillation, hypertension and atherosclerosis lead to cerebral hypoperfusion and ...
Samuel Parker, Andrew F. James, Svetlana Mastitskaya   +2 more
wiley   +1 more source

Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy. [PDF]

Nat Cardiovasc Res
Murphy MR, Ganapathi M, Rotlevi ER, Lee TM, Fisher JM, Patel MV, Jayakar P, Buchanan A, Rippert AL, Ahrens-Nicklas RC, Nair D, Nayak SS, Anand A, Shukla A, Soni RK, Yin Y, Yang F, Garcia EJ, Reilly MP, Chung WK, Wu X.   +20 more
europepmc   +1 more source